Abstract
Ten autopsy eases of Progressive Supranuclear Palsy (PSP) are reported. Age at onset ranged from 16 to 67 years and the duration of illness 3 to 24 years. The clinical features were aggressive mental retardation in 4 cases with early onset, paroxysmal dysequilibrium, ophthalmoplegia, rigidity and akinesia, pseudobulbär palsy and variable degrees of dementia. Neuropathology showed widespread neurofibrillary degeneration associated with system-bound neuronal loss and gliosis in subcortical areas, particularly affecting the subthalamic nucleus, substantia nigra, brainstem tegmentum and dentate nuclei, with no or little involvement of the cerebral cortex. The distribution of the lesions and the ultrastructure of the neurofibrillary tangles made of 15 nm straight filaments (seen in one case) in PSP are different from postencephalitic parkinsonism, Guam Parkinson-dementia complex and brainstem affection in (pre)senile dementia. Post-mortem biochemical analysis of two brains disclosed severe reduction of tyrosine hydroxylase, the key synthetic enzyme of the catecholamine pathway, not only in the nigrostriatal system as seen in Parkinson’s disease, but in most areas of the brainstem and limbic system. The implication and possible pathogenic and therapeutic significance of these biochemical findings are discussed. The etiology of PSP and its nosological position within the degenerative extrapyramidal disorders remain unknown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert, M. L., Feldman, R. G., Willis, A. L.: “The subcortical dementia” of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiat. 37, 121–130 (1974).
Barbeau, A.: Degenerescence plurissystematisee du nevrauxe. Syndrome de Steele-Richardson-Olszewski. Un. med. Canada 94, 715–718 (1965).
Birkmayer, W., Danielczyk, W., Neumayer, E., Riederer, P.: Nucleus ruber and L-Dopa psychosis. Biochemical post-mortem findings. J. Neural Transm. 35, 93–116 (1974).
Birkmayer, W., Riederer, P.: Responsibility of extrastriatal areas for the appearance of psychotic symptoms. J. Neural Transm. 37, 175–182 (1975).
Bugiani, L., Mancardi, G. L., Brusa, A., Ederli, E.; The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropath. (Berlin) 45, 147–152 (1979).
Colmant, H.: Progressive supranuclear palsy. Arch. Psychiat. Nervenkr. 214, 324–330 (1971).
Constantinidis, J., Tissot, R., De Ajuriaguerra, J.: Dystonie oculo-facio- cervicale ou paralysie progressive supranucleaire de Steele-Richardson- Olszewski. Rev. neurol. 122, 249–262 (1970).
Hirano, A., Malamud, N., Elizan, T. S., Kurland, L. T.: Amyotrophic lateral sclerosis and Parkinson-dementia complex on Guam. Arch. Neurol. (Chic.) 15, 35–51 (1966).
Ishii, Y., Itoh, T.: An autopsy case of progressive supranuclear palsy. Clin. Neurol. (Tokyo) 19, 187 (1979).
Ishino, H., Ikeda, H., Otsuki, S.: Contribution to the clinical pathology of progressive supranuclear palsy (subcortical argyrophilic dystrophy). J. Neurol. Sci. 24, 471–481 (1975).
Jellinger, K.: Progressive supranuclear palsy (subcortical argyrophilic dystrophy). Acta Neuropath. (Berlin) 19, 347–352 (1971).
Klawans, H. L., Ringel, S. P.; Observations on the efficacy of L-Dopa in progressive supranuclear palsy. Europ. Neurol. 5, 115–129 (1975).
Kurihara, T., Landau, W. M., Torack, R. M.: Progressive supranuclear palsy with actions myoclonus, seizures. Neurology (Minneap.) 24, 219–223 (1971).
Mastaglia, F. L., Grainger, K. M. R.: Internuclear opthalmoplegia in progressive supranuclear palsy. J. Neurol. Sci. 25, 303–308 (1975).
McGeer, E. G., Gibson, S., McGeer, P. L.: Some characteristics of brain tyrosine hydroxylase. Canad. J. Biochem. 45, 1557–1563 (1967).
McGeer, P. L., Hattori, T., Singh, V. K., McGeer, E. G.: Cholinergic symptoms on extrapyramidal function. In: Basal Ganglia (Ahr, M. D., ed.), pp. 213–222. New York: Plenum Press. 1976.
Mendeil, J. R., Chase, T. N., Engel, W. K.: Modifikation by L-Dopa of a case of progressive supranuclear palsy. With evidence of defective cerebral dopamine metabolism. Lancet I, 593–594 (1970).
Morax, P. U., Aron-Rosa, D., Barthold, I., Contamin, F., Mignot, M.: Les paralysies supranucleaires progressives. Ann. Oculist (Paris) 207, 267 to 278 (1974).
Nagatsu, T., Kato, T., Numata, Y., Ikuta, K., Sano, M., et al.: Phenyl- ethanolamine-N-methyl transferase and other enzymes of catecholamine metabolism in human brain. Clin. Chim. Acta 75, 221–232 (1977).
Owen, F., Gross, A.J., Crow, T.J., Reynolds, G., Riederer, P.: In preparation.
Perkin, G. D., Lees, A.J., Stern, G. M., Kolen, R. S.: Problems in the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski Syndrome). Canad. J. Neurol. Sci. 5, 167–173 (1978).
Powell, H. C., London, G. W., Lantpert, P. W.: Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. J. Neuropath. exp. Neurol. 33, 98–106 (1974).
Probst, A.: Dégénérescence de neurofibrillaire sous-corticale senile avec presence de tubule contournes et de filaments droits. Forme atypique de la paralysie supranucleaire progressive. Rev. Neurol. 133, 417–428 (1977).
Probst, A., Dufresne, J.,: Paralysie supranucleaire progressive ou dystonie oculo-facio-cervicale. Arch. Suisses Neurol. Neurochir. Psychiat. 116, 107–134 (1975).
Riederer, P., Rausch, W. D., Birkmayer, W., Jellinger, K., Seemann, D.: CNS modulation of adrenal tyrosine hydroxylase in Parkinson’s disease and metabolic eneephalopathies. J. Neural Transm., Suppl. 14, 121–131. Wien-New York: Springer. 1978.
Riederer, P., Wuketich, S.: Time course of nigrostriatal degeneration in Parkinson’s disease. J. Neural Transm. 38, 277–301 (1976).
Rouzaud, M., Degiovanni, E., Jobard, P., Gray, E., Durand, J. P.: L’ophthalmoplegie supranucleaire progressive (Syndrome de Steele- Richardson-Olszewski). Rev. Neurol. 130, 143–164 (1974).
Roy, S., Datta, C. K., Hirano, A., Ghatak, N. R., Zimmerman, H. M.: Electron microscopic study of neurofibrillary tangles in Steele- Richardson-Olszewski Syndrome. Acta Neuropath. (Berlin) 29, 175 to 179 (1974).
Seitelb erger, F: Heterogenous system degeneration. Subcortical argyrophilic dystrophy. Acta Neurol. (Napoli) 24, 276–284 (1969).
Steele, J. C.: Progressive supranuclear palsy. Brain 95, 693–704 (1972).
Steele, J. C., Richardson, J. C., Olszewski, J.: Progressive supranuclear palsy. Arch. Neurol. (Chic.) 10, 333–359 (1964).
Stevens, J. R., Livermore, A., jr.: Kindling of the mesolimbic dopamine system: Animal model of psychosis. Neurology (Minneap.) 28, 36–46 (1978).
Tellez-Nagel, I., Wisniewski, H. M.: Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski Syndrome. Arch. Neurol. (Chic.) 29, 324–327 (1973).
Tomonaga, M.: Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropath. (Berlin) 37, 177–181 (1977).
Troost, B. T., Daroff, R. B.: The ocular motor defects in progressive supranuclear palsy. Ann. Neurol. 2, 397–403 (1977).
Yagishita, S., Itoh, Y., Amano, N., Nakano, T., Saitoh, A.: Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neuropath. (Berlin) 48, 27–30 (1979).
Wisniewski, H. M., Soffer, D.: Neurofibrillary pathology: current status and research perspectives. Mech. Ageing Developm. 9, 119–142 (1979).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag
About this chapter
Cite this chapter
Jellinger, K., Riederer, P., Tomonaga, M. (1980). Progressive Supranuclear Palsy: Clinico-Pathological and Biochemical Studies. In: Carlsson, A., Jellinger, K., Riederer, P. (eds) Current Topics in Extrapyramidal Disorders. Journal of Neural Transmission, vol 16. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8582-7_12
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8582-7_12
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-8584-1
Online ISBN: 978-3-7091-8582-7
eBook Packages: Springer Book Archive